4//SEC Filing
HELLUMS RHONDA LYNETTE 4
Accession 0001209191-19-007450
CIK 0001509190other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 5:48 PM ET
Size
7.3 KB
Accession
0001209191-19-007450
Insider Transaction Report
Form 4
HELLUMS RHONDA LYNETTE
CHIEF FINANCIAL OFFICER
Transactions
- Award
Common Stock
2019-02-01+24,923→ 51,424 total - Award
Stock Option (Right to Buy)
2019-02-01+67,527→ 67,527 totalExercise: $4.44Exp: 2029-01-31→ Common Stock (67,527 underlying)
Footnotes (1)
- [F1]Vests as to 25% of the total number of shares (rounded down to the nearest whole share) on February 1, 2020 and as to an additional 1/48th of the total number of shares (rounded down to the nearest whole share) on the same day of each of the 36 successive calendar months thereafter, such that the stock option shall be vested as to all shares on February 1, 2023, subject to continued service with the Issuer through the applicable vesting dates.
Documents
Issuer
ARATANA THERAPEUTICS, INC.
CIK 0001509190
Entity typeother
Related Parties
1- filerCIK 0001766456
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 5:48 PM ET
- Size
- 7.3 KB